Global mRNA Transcriptome Sequencing 麻豆原创 Growth (Status and Outlook) 2025-2031

Publication ID:

LPI06250070

Publication Date:

June 17, 2025

Pages:

137

Publisher:

LPI

Countries:

Global [1]

USD 3,660.00

IT Services [2]

Software [3]

Computing & Electronics [4]

Description:

The global mRNA Transcriptome Sequencing market size is predicted to grow from US$ 4922 million in 2025 to US$ 11730 million in 2031; it is expected to grow at a CAGR of 15.6% from 2025 to 2031.
In molecular biology, messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.
Transcriptome sequencing, or RNA sequencing (RNA-Seq), provides fundamental insights into how genomes are organized and regulated鈥攇iving us valuable information about the internal state of cells and how altered expression of genetic variants contributes to complex disease research.
Need for new platforms for accurate RNA data interpretation and advancements made in bioinformatics, rise in cases of metabolic disorders, multiple sclerosis, and other diseases, growing demand for RNA Sequencing over the conventional technology, are factors that drive the growth of the mRNA sequencing market. In addition, increase in healthcare expenditure; partnerships & collaborations between key players to facilitate development; rise in R&D activities are factors that boost the market growth for mRNA sequencing. However, the need for skilled professionals, the huge initial capital investment on infrastructure, problems associated with the storage of sequencing data are factors that hinder the mRNA sequencing market growth.
The 鈥渕RNA Transcriptome Sequencing Industry Forecast鈥� looks at past sales and reviews total world mRNA Transcriptome Sequencing sales in 2024, providing a comprehensive analysis by region and market sector of projected mRNA Transcriptome Sequencing sales for 2025 through 2031. With mRNA Transcriptome Sequencing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world mRNA Transcriptome Sequencing industry.
This Insight Report provides a comprehensive analysis of the global mRNA Transcriptome Sequencing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on mRNA Transcriptome Sequencing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms鈥� unique position in an accelerating global mRNA Transcriptome Sequencing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for mRNA Transcriptome Sequencing and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global mRNA Transcriptome Sequencing.
This report presents a comprehensive overview, market shares, and growth opportunities of mRNA Transcriptome Sequencing market by product type, application, key players and key regions and countries.
Segmentation by Type:
Next Generation Sequencing
Single Molecule Sequencing
Others
Segmentation by Application:
Biomedical Field
Non-medical Field
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Illumina
Thermo Fisher Scientific
Bio-Rad
Agilent Technologies
QIAGEN
Roche
Pacific Biosciences
Eurofins Scientific
Azenta
LabCorp
BGI Tech Solutions
Zhijiang Biology
Novogene Co.
Macrogen
Tsingke Biotechnology
Oxford Nanopore Technologies
PerkinElmer, Inc.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 Scope of the Report
1.1 麻豆原创 Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 麻豆原创 Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 麻豆原创 Estimation Caveats
2 Executive Summary
2.1 World 麻豆原创 Overview
2.1.1 Global mRNA Transcriptome Sequencing 麻豆原创 Size (2020-2031)
2.1.2 mRNA Transcriptome Sequencing 麻豆原创 Size CAGR by Region (2020 VS 2024 VS 2031)
2.1.3 World Current & Future Analysis for mRNA Transcriptome Sequencing by Country/Region (2020, 2024 & 2031)
2.2 mRNA Transcriptome Sequencing Segment by Type
2.2.1 Next Generation Sequencing
2.2.2 Single Molecule Sequencing
2.2.3 Others
2.3 mRNA Transcriptome Sequencing 麻豆原创 Size by Type
2.3.1 mRNA Transcriptome Sequencing 麻豆原创 Size CAGR by Type (2020 VS 2024 VS 2031)
2.3.2 Global mRNA Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Type (2020-2025)
2.4 mRNA Transcriptome Sequencing Segment by Application
2.4.1 Biomedical Field
2.4.2 Non-medical Field
2.5 mRNA Transcriptome Sequencing 麻豆原创 Size by Application
2.5.1 mRNA Transcriptome Sequencing 麻豆原创 Size CAGR by Application (2020 VS 2024 VS 2031)
2.5.2 Global mRNA Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Application (2020-2025)
3 mRNA Transcriptome Sequencing 麻豆原创 Size by Player
3.1 mRNA Transcriptome Sequencing 麻豆原创 Size 麻豆原创 Share by Player
3.1.1 Global mRNA Transcriptome Sequencing Revenue by Player (2020-2025)
3.1.2 Global mRNA Transcriptome Sequencing Revenue 麻豆原创 Share by Player (2020-2025)
3.2 Global mRNA Transcriptome Sequencing Key Players Head office and Products Offered
3.3 麻豆原创 Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 mRNA Transcriptome Sequencing by Region
4.1 mRNA Transcriptome Sequencing 麻豆原创 Size by Region (2020-2025)
4.2 Global mRNA Transcriptome Sequencing Annual Revenue by Country/Region (2020-2025)
4.3 Americas mRNA Transcriptome Sequencing 麻豆原创 Size Growth (2020-2025)
4.4 APAC mRNA Transcriptome Sequencing 麻豆原创 Size Growth (2020-2025)
4.5 Europe mRNA Transcriptome Sequencing 麻豆原创 Size Growth (2020-2025)
4.6 Middle East & Africa mRNA Transcriptome Sequencing 麻豆原创 Size Growth (2020-2025)
5 Americas
5.1 Americas mRNA Transcriptome Sequencing 麻豆原创 Size by Country (2020-2025)
5.2 Americas mRNA Transcriptome Sequencing 麻豆原创 Size by Type (2020-2025)
5.3 Americas mRNA Transcriptome Sequencing 麻豆原创 Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC mRNA Transcriptome Sequencing 麻豆原创 Size by Region (2020-2025)
6.2 APAC mRNA Transcriptome Sequencing 麻豆原创 Size by Type (2020-2025)
6.3 APAC mRNA Transcriptome Sequencing 麻豆原创 Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe mRNA Transcriptome Sequencing 麻豆原创 Size by Country (2020-2025)
7.2 Europe mRNA Transcriptome Sequencing 麻豆原创 Size by Type (2020-2025)
7.3 Europe mRNA Transcriptome Sequencing 麻豆原创 Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa mRNA Transcriptome Sequencing by Region (2020-2025)
8.2 Middle East & Africa mRNA Transcriptome Sequencing 麻豆原创 Size by Type (2020-2025)
8.3 Middle East & Africa mRNA Transcriptome Sequencing 麻豆原创 Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 麻豆原创 Drivers, Challenges and Trends
9.1 麻豆原创 Drivers & Growth Opportunities
9.2 麻豆原创 Challenges & Risks
9.3 Industry Trends
10 Global mRNA Transcriptome Sequencing 麻豆原创 Forecast
10.1 Global mRNA Transcriptome Sequencing Forecast by Region (2026-2031)
10.1.1 Global mRNA Transcriptome Sequencing Forecast by Region (2026-2031)
10.1.2 Americas mRNA Transcriptome Sequencing Forecast
10.1.3 APAC mRNA Transcriptome Sequencing Forecast
10.1.4 Europe mRNA Transcriptome Sequencing Forecast
10.1.5 Middle East & Africa mRNA Transcriptome Sequencing Forecast
10.2 Americas mRNA Transcriptome Sequencing Forecast by Country (2026-2031)
10.2.1 United States 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.2.2 Canada 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.2.3 Mexico 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.2.4 Brazil 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.3 APAC mRNA Transcriptome Sequencing Forecast by Region (2026-2031)
10.3.1 China mRNA Transcriptome Sequencing 麻豆原创 Forecast
10.3.2 Japan 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.3.3 Korea 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.3.4 Southeast Asia 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.3.5 India 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.3.6 Australia 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.4 Europe mRNA Transcriptome Sequencing Forecast by Country (2026-2031)
10.4.1 Germany 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.4.2 France 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.4.3 UK 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.4.4 Italy 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.4.5 Russia 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.5 Middle East & Africa mRNA Transcriptome Sequencing Forecast by Region (2026-2031)
10.5.1 Egypt 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.5.2 South Africa 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.5.3 Israel 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.5.4 Turkey 麻豆原创 mRNA Transcriptome Sequencing Forecast
10.6 Global mRNA Transcriptome Sequencing Forecast by Type (2026-2031)
10.7 Global mRNA Transcriptome Sequencing Forecast by Application (2026-2031)
10.7.1 GCC Countries 麻豆原创 mRNA Transcriptome Sequencing Forecast
11 Key Players Analysis
11.1 Illumina
11.1.1 Illumina Company Information
11.1.2 Illumina mRNA Transcriptome Sequencing Product Offered
11.1.3 Illumina mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.1.4 Illumina Main Business Overview
11.1.5 Illumina Latest Developments
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Information
11.2.2 Thermo Fisher Scientific mRNA Transcriptome Sequencing Product Offered
11.2.3 Thermo Fisher Scientific mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.2.4 Thermo Fisher Scientific Main Business Overview
11.2.5 Thermo Fisher Scientific Latest Developments
11.3 Bio-Rad
11.3.1 Bio-Rad Company Information
11.3.2 Bio-Rad mRNA Transcriptome Sequencing Product Offered
11.3.3 Bio-Rad mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.3.4 Bio-Rad Main Business Overview
11.3.5 Bio-Rad Latest Developments
11.4 Agilent Technologies
11.4.1 Agilent Technologies Company Information
11.4.2 Agilent Technologies mRNA Transcriptome Sequencing Product Offered
11.4.3 Agilent Technologies mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.4.4 Agilent Technologies Main Business Overview
11.4.5 Agilent Technologies Latest Developments
11.5 QIAGEN
11.5.1 QIAGEN Company Information
11.5.2 QIAGEN mRNA Transcriptome Sequencing Product Offered
11.5.3 QIAGEN mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.5.4 QIAGEN Main Business Overview
11.5.5 QIAGEN Latest Developments
11.6 Roche
11.6.1 Roche Company Information
11.6.2 Roche mRNA Transcriptome Sequencing Product Offered
11.6.3 Roche mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.6.4 Roche Main Business Overview
11.6.5 Roche Latest Developments
11.7 Pacific Biosciences
11.7.1 Pacific Biosciences Company Information
11.7.2 Pacific Biosciences mRNA Transcriptome Sequencing Product Offered
11.7.3 Pacific Biosciences mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.7.4 Pacific Biosciences Main Business Overview
11.7.5 Pacific Biosciences Latest Developments
11.8 Eurofins Scientific
11.8.1 Eurofins Scientific Company Information
11.8.2 Eurofins Scientific mRNA Transcriptome Sequencing Product Offered
11.8.3 Eurofins Scientific mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.8.4 Eurofins Scientific Main Business Overview
11.8.5 Eurofins Scientific Latest Developments
11.9 Azenta
11.9.1 Azenta Company Information
11.9.2 Azenta mRNA Transcriptome Sequencing Product Offered
11.9.3 Azenta mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.9.4 Azenta Main Business Overview
11.9.5 Azenta Latest Developments
11.10 LabCorp
11.10.1 LabCorp Company Information
11.10.2 LabCorp mRNA Transcriptome Sequencing Product Offered
11.10.3 LabCorp mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.10.4 LabCorp Main Business Overview
11.10.5 LabCorp Latest Developments
11.11 BGI Tech Solutions
11.11.1 BGI Tech Solutions Company Information
11.11.2 BGI Tech Solutions mRNA Transcriptome Sequencing Product Offered
11.11.3 BGI Tech Solutions mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.11.4 BGI Tech Solutions Main Business Overview
11.11.5 BGI Tech Solutions Latest Developments
11.12 Zhijiang Biology
11.12.1 Zhijiang Biology Company Information
11.12.2 Zhijiang Biology mRNA Transcriptome Sequencing Product Offered
11.12.3 Zhijiang Biology mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.12.4 Zhijiang Biology Main Business Overview
11.12.5 Zhijiang Biology Latest Developments
11.13 Novogene Co.
11.13.1 Novogene Co. Company Information
11.13.2 Novogene Co. mRNA Transcriptome Sequencing Product Offered
11.13.3 Novogene Co. mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.13.4 Novogene Co. Main Business Overview
11.13.5 Novogene Co. Latest Developments
11.14 Macrogen
11.14.1 Macrogen Company Information
11.14.2 Macrogen mRNA Transcriptome Sequencing Product Offered
11.14.3 Macrogen mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.14.4 Macrogen Main Business Overview
11.14.5 Macrogen Latest Developments
11.15 Tsingke Biotechnology
11.15.1 Tsingke Biotechnology Company Information
11.15.2 Tsingke Biotechnology mRNA Transcriptome Sequencing Product Offered
11.15.3 Tsingke Biotechnology mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.15.4 Tsingke Biotechnology Main Business Overview
11.15.5 Tsingke Biotechnology Latest Developments
11.16 Oxford Nanopore Technologies
11.16.1 Oxford Nanopore Technologies Company Information
11.16.2 Oxford Nanopore Technologies mRNA Transcriptome Sequencing Product Offered
11.16.3 Oxford Nanopore Technologies mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.16.4 Oxford Nanopore Technologies Main Business Overview
11.16.5 Oxford Nanopore Technologies Latest Developments
11.17 PerkinElmer, Inc.
11.17.1 PerkinElmer, Inc. Company Information
11.17.2 PerkinElmer, Inc. mRNA Transcriptome Sequencing Product Offered
11.17.3 PerkinElmer, Inc. mRNA Transcriptome Sequencing Revenue, Gross Margin and 麻豆原创 Share (2020-2025)
11.17.4 PerkinElmer, Inc. Main Business Overview
11.17.5 PerkinElmer, Inc. Latest Developments
12 Research Findings and Conclusion

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.